×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北京... [5]
山东大学 [2]
内容类型
期刊论文 [7]
发表日期
2018 [3]
2016 [1]
2015 [1]
2013 [2]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共7条,第1-7条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
EGFR-targeting, beta-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis
期刊论文
ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 11, 页码: 1777-1786
作者:
Liu, Wen-Juan
;
Liu, Xiu-Jun
;
Xu, Jian
;
Li, Liang
;
Li, Yi
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/11
defensin
recombinant protein
EGFR-targeting
lidamycin apoprotein
mitochondria-mediated apoptosis
human epidermoid carcinoma A431 cells
human lung carcinoma A549 cells
human lung carcinoma H460 cells
EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis
期刊论文
Acta Pharmacologica Sinica, 2018, 页码: 1-10
作者:
Liu W.-J.
;
Liu X.-J.
;
Xu J.
;
Li L.
;
Li Y.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/11
defensin
EGFR-targeting
human epidermoid carcinoma A431 cells
human lung carcinoma A549 cells
human lung carcinoma H460 cells
lidamycin apoprotein
mitochondria-mediated apoptosis
recombinant protein
EGFR-targeting, beta-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis
期刊论文
2018, 卷号: 39, 期号: 11, 页码: 1777-1786
作者:
Liu, Wen-Juan
;
Liu, Xiu-Jun
;
Xu, Jian
;
Li, Liang
;
Li, Yi
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
defensin
recombinant protein
EGFR-targeting
lidamycin apoprotein
mitochondria-mediated apoptosis
human epidermoid carcinoma A431 cells
human lung carcinoma A549 cells
human lung carcinoma H460 cells
Construction of a genetically engineered chimeric apoprotein consisting of sequences derived from lidamycin and neocarzinostatin
期刊论文
2016, 卷号: 27, 期号: 1, 页码: 24-28
作者:
Jiang, Wenguo
;
Shang, Boyang
;
Li, Liang
;
Zhang, Shenghua
;
Zhen, Yongsu
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
antitumor activity
chimeric apoprotein
drug delivery
enediyne antibiotics
lidamycin
neocarzinostatin
A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity
期刊论文
2015, 卷号: 26, 期号: 1, 页码: 64-73
作者:
Zhu, Daqiang
;
Wang, Xiaofei
;
Shang, Yue
;
Li, Yi
;
Jiang, Wenguo
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/13
death receptor 4
death receptor 5
epidermal growth factor receptor
lidamycin
TRAIL
An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity
期刊论文
2013, 卷号: 67, 期号: 2, 页码: 164-171
作者:
Zheng, Yan-bo
;
Shang, Bo-yang
;
Li, Yi
;
Zhen, Yong-su
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/13
NGR
CD13
Lidamycin
Angiogenesis
Optimization of the preparation process for fusion protein Fv-LDP that composes lidamycin apoprotein and single-chain Fv antibody directed against type IV collagenase
期刊论文
2013, 卷号: 48, 期号: 10, 页码: 1563-9
作者:
Gao Rui-Juan
;
Zhao Chun-Yan
;
Li Dian-Dong
;
Zhen Yong-Su
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/13
©版权所有 ©2017 CSpace - Powered by
CSpace